Table 1.
Differences in quality of life by demographic and clinical characteristics (N=145)
| Characteristics | Levels | Overall, N=145
|
Physical functioning, 54.5±28.8
|
Role limitations due to physical health, 29.3±38.3
|
Role limitations due to emotional problems, 33.6±42.1
|
|||
|---|---|---|---|---|---|---|---|---|
| n (%) | Mean (SD) | P-value | Mean (SD) | P-value | Mean (SD) | P-value | ||
| Elderly | No | 113 (77.9) | 58.4 (27.6) | 0.002* | 27.4 (37.6) | 0.270 | 31.9 (41.2) | 0.363 |
| Yes | 32 (22.1) | 40.5 (28.7) | 35.9 (40.6) | 39.6 (45.9) | ||||
| University | No | 98 (67.6) | 48.7 (26.8) | 0.001* | 30.1 (38.0) | 0.721 | 34.0 (41.7) | 0.854 |
| Yes | 47 (32.4) | 66.4 (29.2) | 27.7 (39.4) | 32.6 (43.7) | ||||
| Employed | No | 108 (74.5) | 51.1 (27.0) | 0.015 | 31.0 (38.6) | 0.361 | 37.3 (43.6) | 0.045 |
| Yes | 37 (25.5) | 64.3 (31.6) | 24.3 (37.5) | 22.5 (36.1) | ||||
| Married | No | 37 (25.5) | 49.1 (28.9) | 0.187 | 31.1 (36.5) | 0.746 | 31.5 (38.4) | 0.736 |
| Yes | 108 (74.5) | 56.3 (28.6) | 28.7 (39.1) | 34.3 (43.6) | ||||
| Obese | No | 76 (62.8) | 53.9 (28.3) | 0.741 | 34.2 (41.4) | 0.194 | 34.2 (44.2) | 0.869 |
| Yes | 45 (37.2) | 55.8 (31.2) | 25.0 (35.0) | 35.6 (41.7) | ||||
| Family history of cancer | No | 84 (57.9) | 54.0 (29.1) | 0.882 | 35.1 (40.2) | 0.028 | 38.5 (44.7) | 0.091 |
| Yes | 61 (42.1) | 55.1 (28.4) | 21.3 (34.4) | 26.8 (37.9) | ||||
| First-year-after-cancer diagnosis | No | 69 (47.6) | 52.4 (27.3) | 0.414 | 25.7 (35.1) | 0.281 | 32.4 (40.4) | 0.745 |
| Yes | 76 (52.4) | 56.3 (30.0) | 32.6 (41.0) | 34.6 (44.0) | ||||
| Cancer stage | I/II | 79 (61.2) | 61.5 (27.6) | 0.005 | 31.3 (38.3) | 0.489 | 40.1 (44.1) | 0.016 |
| III/IV | 50 (38.8) | 47.0 (28.2) | 26.5 (38.9) | 22.7 (35.9) | ||||
| Multiple tumors | No | 108 (74.5) | 58.9 (27.9) | 0.001* | 32.2 (39.7) | 0.095 | 41.4 (44.4) | 0.001* |
| Yes | 37 (25.5) | 41.5 (27.5) | 20.9 (33.1) | 10.8 (23.6) | ||||
| Cancer surgery | No | 51 (35.2) | 56.2 (30.9) | 0.596 | 33.8 (40.9) | 0.298 | 31.4 (41.3) | 0.647 |
| Yes | 94 (64.8) | 53.5 (27.6) | 26.9 (36.9) | 34.8 (42.9) | ||||
| Chemotherapy | No | 39 (26.9) | 55.0 (28.4) | 0.889 | 34.6 (39.2) | 0.314 | 35.9 (44.2) | 0.688 |
| Yes | 106 (73.1) | 54.2 (29.0) | 27.4 (38.0) | 32.7 (41.7) | ||||
| Radiation therapy | No | 61 (42.1) | 52.8 (30.6) | 0.555 | 30.7 (38.8) | 0.704 | 27.3 (37.8) | 0.120 |
| Yes | 84 (57.9) | 55.7 (27.5) | 28.3 (38.2) | 38.1 (44.9) | ||||
| Immunotherapy | No | 74 (51.0) | 61.8 (28.0) | 0.001* | 33.8 (41.7) | 0.151 | 39.6 (44.7) | 0.076 |
| Yes | 71 (49.0) | 46.8 (27.7) | 24.6 (34.2) | 27.2 (38.8) | ||||
| Antibodies | No | 102 (72.3) | 57.3 (27.5) | 0.074 | 29.7 (38.0) | 0.949 | 35.9 (43.4) | 0.453 |
| Yes | 39 (27.7) | 47.6 (31.6) | 30.1 (40.6) | 29.9 (40.3) | ||||
| Metastasis | No | 101 (69.7) | 60.3 (26.4) | 0.001* | 31.4 (38.8) | 0.314 | 41.6 (44.6) | 0.001* |
| Yes | 44 (30.3) | 40.9 (29.7) | 24.4 (37.2) | 15.2 (29.2) | ||||
| Fever | No | 91 (62.8) | 56.1 (30.1) | 0.371 | 33.5 (39.8) | 0.086 | 41.0 (44.7) | 0.003* |
| Yes | 54 (37.2) | 51.7 (26.3) | 22.2 (34.9) | 21.0 (34.4) | ||||
| Family support | No | 14 (9.7) | 62.9 (32.0) | 0.251 | 21.4 (33.8) | 0.420 | 31.0 (46.2) | 0.809 |
| Yes | 131 (90.3) | 53.5 (28.4) | 30.2 (38.8) | 33.8 (42.0) | ||||
| Chronic disease other than cancer | No | 93 (64.1) | 59.3 (27.9) | 0.006 | 30.1 (40.0) | 0.739 | 31.2 (41.6) | 0.366 |
| Yes | 52 (35.9) | 45.8 (28.5) | 27.9 (35.6) | 37.8 (43.3) | ||||
| Regular exercise | No | 99 (68.3) | 51.8 (29.5) | 0.106 | 29.0 (39.7) | 0.902 | 32.3 (43.0) | 0.606 |
| Yes | 46 (31.7) | 60.1 (26.6) | 29.9 (35.6) | 36.2 (40.9) | ||||
Note:
*
The variable is significant using the Bonferroni correction cutoff at α/n=0.05/19=0.003, where n is the number of tests.
Abbreviation: SD, standard deviation.